Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Sortiert nach
Open Access
    Datensatz exportieren als...
  • BibTeX
Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study
Neurology, 2020-10, Vol.95 (14), p.e1999
2020
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
P038 Ozanimod First-Dose Cardiac Effects in Patients with Moderately to Severely Active Ulcerative Colitis and Relapsing Multiple Sclerosis
The American journal of gastroenterology, 2021-12, Vol.116 (Suppl 1), p.S9-S10
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Re-evaluating the treatment of acute optic neuritis
Journal of Neurology, Neurosurgery and Psychiatry, 2015-07, Vol.86 (7), p.799-808
2015
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis
Lancet neurology, 2017-10, Vol.16 (10), p.797-812
2017
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Optic neuritis: Both eyes improve after corticotropin
Journal of the neurological sciences, 2019-12, Vol.407, p.116504-116504, Article 116504
2019
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial
Lancet neurology, 2020-12, Vol.19 (12), p.988-997
2020
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial
Lancet neurology, 2022-07, Vol.21 (7), p.608-619
2022
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Assessing ‘No Evidence of Disease Activity’ Status in Patients with Relapsing-Remitting Multiple Sclerosis Receiving Fingolimod in Routine Clinical Practice: A Retrospective Analysis of the Multiple Sclerosis Clinical and Magnetic Resonance Imaging Outcomes in the USA (MS-MRIUS) Study
CNS drugs, 2018-01, Vol.32 (1), p.75-84
2018
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
15: LONG-TERM CARDIAC SAFETY OF OZANIMOD IN PHASE 3 CLINICAL PROGRAM OF ULCERATIVE COLITIS AND RELAPSING MULTIPLE SCLEROSIS
Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-5-S-6
2022
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Siponimod enriches regulatory T and B lymphocytes in secondary progressive multiple sclerosis
JCI insight, 2020-02, Vol.5 (3)
2020
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
No evidence of disease activity in patients receiving fingolimod at private or academic centers in clinical practice: a retrospective analysis of the multiple sclerosis, clinical, and magnetic resonance imaging outcomes in the USA (MS-MRIUS) study
Current medical research and opinion, 2018-08, Vol.34 (8), p.1431-1440
2018
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Impact of a switch to fingolimod versus staying on glatiramer acetate or beta interferons on patient- and physician-reported outcomes in relapsing multiple sclerosis: post hoc analyses of the EPOC trial
BMC neurology, 2014-11, Vol.14 (1), p.220-220
2014
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Clinical outcomes in patients with relapsing-remitting multiple sclerosis who switch from natalizumab to delayed-release dimethyl fumarate: A multicenter retrospective observational study (STRATEGY)
Multiple sclerosis and related disorders, 2018-05, Vol.22, p.27-34
2018
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
P038 Ozanimod First-Dose Cardiac Effects in Patients with Moderately to Severely Active Ulcerative Colitis and Relapsing Multiple Sclerosis
The American journal of gastroenterology, 2021-12, Vol.116 (Suppl 1), p.S9
2021
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Results from the single-use autoinjector for self-administration of subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis (MOSAIC) study
Expert opinion on drug delivery, 2011-12, Vol.8 (12), p.1543-1553
2011
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Impact of a switch to fingolimod versus staying on glatiramer acetate or beta interferons on patient- and physician-reported outcomes in relapsing multiple sclerosis: post hocanalyses of the EPOC trial
BMC neurology, 2014-11, Vol.14 (1), Article 220
2014
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Safety and Tolerability of Delayed-Release Dimethyl Fumarate Administered with Interferon Beta or Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis
International journal of MS care, 2016-05, Vol.18 (3), p.138-146
2016
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Multicenter evaluation of the Selux Next-Generation Phenotyping antimicrobial susceptibility testing system
Journal of clinical microbiology, 2024-01, Vol.62 (1), p.e0054623-e0054623
2024
Volltextzugriff (PDF)
1 – 18 von 18
Suche als RSS-Feed
Suchergebnisse filtern
Filter anzeigen